Android app Apple app link

VYNE Therapeutics completes enrolment in trial of gel for non-segmental vitiligo

By Yahoo! Finance   |   2 weeks ago
VYNE Therapeutics completes enrolment in trial of gel for non-segmental vitiligo

VYNE Therapeutics finishes enrolling participants in Phase IIb trial testing VYN201 gel for non-segmental vitiligo. The study evaluates safety and efficacy of different concentrations compared to a vehicle, aiming for a 50% improvement in F-VASI50.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.